Compare FSI & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSI | BTMD |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3M | 80.4M |
| IPO Year | 1999 | N/A |
| Metric | FSI | BTMD |
|---|---|---|
| Price | $5.53 | $2.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 56.9K | ★ 168.8K |
| Earning Date | 11-14-2025 | 03-11-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | 0.14 | ★ 0.78 |
| Revenue | $38,563,427.00 | ★ $195,645,000.00 |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $53.12 | $2.80 |
| P/E Ratio | $39.44 | ★ $2.72 |
| Revenue Growth | 0.18 | ★ 1.34 |
| 52 Week Low | $3.46 | $2.03 |
| 52 Week High | $11.48 | $5.15 |
| Indicator | FSI | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.32 | 39.59 |
| Support Level | $5.65 | $2.06 |
| Resistance Level | $6.02 | $2.31 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.43 | 25.59 |
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.